0.4274
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire
ProPhase Labs secures $3 million in convertible notes financing - Investing.com India
Prophase Labs Secures $3 Million in Private Financing - TipRanks
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com
ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru
What analysts say about ProPhase Labs Inc. stockExceptional trading performance - Autocar Professional
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus
ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC - Defense World
ProPhase Labs Announces Formation of Clinical Science Advisory B - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Tes - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):